2192 logo

Medlive Technology SZSC:2192 Stock Report

Last Price

HK$8.27

Market Cap

HK$6.0b

7D

10.1%

1Y

-4.3%

Updated

25 Apr, 2024

Data

Company Financials +

Medlive Technology Co., Ltd.

SZSC:2192 Stock Report

Market Cap: HK$6.0b

Medlive Technology Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Medlive Technology
Historical stock prices
Current Share PriceHK$8.27
52 Week HighHK$9.90
52 Week LowHK$5.59
Beta0.69
1 Month Change13.29%
3 Month Change27.43%
1 Year Change-4.28%
3 Year Changen/a
5 Year Changen/a
Change since IPO-77.53%

Recent News & Updates

Recent updates

Shareholder Returns

2192HK Healthcare ServicesHK Market
7D10.1%5.1%3.6%
1Y-4.3%-30.3%-10.1%

Return vs Industry: 2192 exceeded the Hong Kong Healthcare Services industry which returned -30.3% over the past year.

Return vs Market: 2192 exceeded the Hong Kong Market which returned -10.1% over the past year.

Price Volatility

Is 2192's price volatile compared to industry and market?
2192 volatility
2192 Average Weekly Movement5.9%
Healthcare Services Industry Average Movement7.2%
Market Average Movement7.4%
10% most volatile stocks in HK Market14.6%
10% least volatile stocks in HK Market3.7%

Stable Share Price: 2192's share price has been volatile over the past 3 months.

Volatility Over Time: 2192's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1996742Liping Tianwww.medlive.cn

Medlive Technology Co., Ltd., together with its subsidiaries, operates an online professional physician platform in Mainland China and internationally. Its precision marketing and corporate solution provides full service on its one-site platform, which includes project management, clinical monitoring, clinical data management, biostatistics, protocol design, medical monitoring, patient recruitment, and supporting system, as well as digital market research, electronic data capture, real-world studies, and application software development services. The company’s medical knowledge solution offers medical education and clinical decision support, including licensing software to physicians, other registered users, such as other healthcare professionals and pharmaceutical companies.

Medlive Technology Co., Ltd. Fundamentals Summary

How do Medlive Technology's earnings and revenue compare to its market cap?
2192 fundamental statistics
Market capHK$6.01b
Earnings (TTM)HK$261.80m
Revenue (TTM)HK$445.16m

23.0x

P/E Ratio

13.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2192 income statement (TTM)
RevenueCN¥412.00m
Cost of RevenueCN¥160.67m
Gross ProfitCN¥251.34m
Other ExpensesCN¥9.03m
EarningsCN¥242.30m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.33
Gross Margin61.00%
Net Profit Margin58.81%
Debt/Equity Ratio0%

How did 2192 perform over the long term?

See historical performance and comparison

Dividends

3.3%

Current Dividend Yield

69%

Payout Ratio

Does 2192 pay a reliable dividends?

See 2192 dividend history and benchmarks
When do you need to buy 2192 by to receive an upcoming dividend?
Medlive Technology dividend dates
Ex Dividend DateMay 28 2024
Dividend Pay DateJun 24 2024
Days until Ex dividend32 days
Days until Dividend pay date59 days

Does 2192 pay a reliable dividends?

See 2192 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.